UFT

Title	Average Rating
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.	90.00%
A phase II study of sorafenib in combination with tegafur/uracil (UFT) for Asian patients with advanced hepatocellular carcinoma	80.00%
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high...	80.00%
A case of metronomic chemotherapy as an alternative cancer therapy for palliation	60.00%
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung	50.00%
A phase II trial of thalidomide plus tegafur/uracil for patients with advanced/metastatic hepatocellular carcinoma (HCC)	50.00%
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer.	40.00%

Languages